Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.
Restenosis is due to neointimal hyperplasia, which occurs in the coronary artery after percutaneous transluminal coronary angioplasty (PTCA). During restenosis, an impairment of nitric oxide (NO)-dependent pathways may occur. Concomitant hypercholesterolemia may exacerbate restenosis in patients undergoing PTCA. Here, we show that a NO-releasing aspirin derivative (NCX-4016) reduces the degree of restenosis after balloon angioplasty in low-density lipoprotein receptor-deficient mice and this effect is associated with reduced vascular smooth muscle cell (VSMC) proliferation and macrophage deposition at the site of injury. Drugs were administered following both therapeutic or preventive protocols. We demonstrate that NCX-4016 is effective both in prevention and treatment of restenosis in the presence of hypercholesterolemia. These data indicate that impairment of NO-dependent mechanisms may be involved in the development of restenosis in hypercholesterolemic mice. Although experimental models of restenosis may not reflect restenosis in humans in all details, we suggest that a NO-releasing aspirin derivative could be an effective drug in reducing restenosis following PTCA, especially in the presence of hypercholesterolemia and/or gastrointestinal damage.
Department of Medicine, Federico II University of Naples, 80131 Naples, Italy.
C
C
Napoli
G
G
Cirino
P
P
Del Soldato
R
R
Sorrentino
V
V
Sica
M
M
Condorelli
A
A
Pinto
L J
LJ
Ignarro
D000818:Animals; D001241:Aspirin / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use; D003251:Constriction, Pathologic / Q000188:drug therapy / Q000517:prevention & control*; D006937:Hypercholesterolemia / Q000150:complications*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009569:Nitric Oxide / Q000378:metabolism*; D011973:Receptors, LDL / Q000235:genetics / Q000502:physiology; D012008:Recurrence
D011973:Receptors, LDL; D009569:Nitric Oxide; C102148:nitroaspirin; D001241:Aspirin